Author

Tamás Nyirády

Observed names: Nyirády, Tamás, T Nyirady, T Nyirády, T. Nyirady

Observed institution: Bács-Kiskun Megyei Kórház

OpenAlex ID: A5043642891

A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg

2024 · Kristina Biskupska-Bodova, Joanna Sójka-Kupny, et al. · The European Journal of Contraception & Reproductive Health Care · 14

69. Relugolix combination therapy in European women with symptomatic uterine fibroids in the liberty long-term extension (lte) study

2022 · R. Venturella, A. Al-Hendy, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 1

O-136 Once-daily relugolix combination therapy results in sustained reduction in symptoms and improved quality of life in women with uterine fibroids treated over 52 weeks

2021 · A Lukes, R Venturella, et al. · Human Reproduction · 1

A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg

2026 · P A Regidor, K Biskupska-Bodova, et al. · Geburtshilfe und Frauenheilkunde

Works count: 5

Citation count: 16

H-index: 1

I10-index: 1